title: Development of an aqueous two-phase partitioning system for fractionating therapeutic proteins from tobacco extract.
abstract: In the present study, an aqueous two-phase partitioning system (ATPS) was developed and evaluated as an initial fractionation step for therapeutic antibodies and enzymes from tobacco extracts. A detailed study has been performed to analyze the effect of pH, ionic composition of the system, types of polymers and their molecular weight and concentration, on the partitioning behavior of tobacco proteins and human anti-human immunodeficiency virus (HIV) monoclonal antibody 2F5 (mAb 2F5). A polyethyleneglycol/phosphate (PEG/Pi) aqueous two-phase system composed of 12% (w/w) PEG 1500 and 13% (w/w) phosphate buffer, pH 5, was selected as the system with the highest selectivity of antibody over native tobacco proteins. Under selected conditions, sufficient purification (3-4-fold) with high recovery at the bottom phase (approximately 95%) was achieved for mAb 2F5. In addition, the system allows removal of plant-derived compounds, such as phenolics and toxic alkaloids. The antibody fraction may be directly applied to a Protein A affinity column without any further pre-treatment, thus allowing homogenous antibody preparation. Analysis of the purified antibody fraction by enzyme-linked immunosorbent assay (ELISA) and western blot showed that the antibody was fully active and free of degraded variants or modified forms. The efficacy of the system was further demonstrated using additional proteins and enzymes of therapeutic importance, such as neuraminidase (NA) from influenza virus and human anti-HIV monoclonal antibody 2G12 (mAb 2G12), and showed that the system may find wide applicability as an economic extraction strategy for the initial fractionation of biopharmaceuticals from transgenic tobacco plants.
authors.affiliation: Laboratory of Enzyme Technology, Department of Agricultural Biotechnology, Agricultural University of Athens, 75 Iera Odos, GR 118 55 Athens, Greece.
authors.forename: Dimitris
authors.initials: D
authors.lastname: Platis
authors.forename: Nikolaos E
authors.initials: NE
authors.lastname: Labrou
mesh_terms: D005591:Chemical Fractionation / Q000379:methods*; D002846:Chromatography, Affinity; D015483:HIV Antibodies / Q000737:chemistry / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008954:Models, Biological; D010710:Phosphates / Q000737:chemistry; D010936:Plant Extracts / Q000737:chemistry; D018515:Plant Leaves / Q000737:chemistry; D010940:Plant Proteins / Q000302:isolation & purification; D030821:Plants, Genetically Modified / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000737:chemistry; D011994:Recombinant Proteins / Q000302:isolation & purification* / Q000627:therapeutic use; D013205:Staphylococcal Protein A / Q000737:chemistry; D014026:Nicotiana / Q000235:genetics*
chemical_list: D015483:HIV Antibodies; D010710:Phosphates; D010936:Plant Extracts; D010940:Plant Proteins; D011994:Recombinant Proteins; D013205:Staphylococcal Protein A; D011092:Polyethylene Glycols